Search
SOLACI Congress
HomeFile

File

View Category
Coronary disease

IVUS Optimized Left Main 2-Stent Strategy: Should We Drop the 5-6-7-8 Criterion?

Provisional stenting in bifurcations has shown better results at mid and long term vs initial two stent...
Dr. Omar Tupayachi -
Learn More
Mitral valve

Edge-to-Edge Tricuspid Valve Repair 3-Year Follow Up

Tricuspid regurgitation (TR) is associated to fatigue and peripheral edema, and medical treatment with diuretics has a...
Dr. Carlos Fava -
Learn More
Antithrombotic Anticoagulants

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral...
Dr. Carlos Fava -
Learn More
Acute coronary syndromes

Recently Diagnosed Atrial Fibrillation in Patients with Acute Coronary Syndrome: Results of the FORCE-ACS Registry

Atrial fibrillation (AF) is a common condition in patients with acute coronary syndrome (ACS). About 10% of...
Dr. Carlos Fava -
Learn More
Structural heart disease

MATTERHORN: Edge-to-Edge Repair vs. Surgery for Secondary Mitral Valve Regurgitation

Frequently associated with hospitalization for cardiac failure and mortality, secondary mitral valve regurgitation (MR) is the most...
Dr. Carlos Fava -
Learn More
Chronic Coronary Syndromes

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

ESC 2024 | The OCCUPI Trial: Guided PCI for OCT in Complex Lesions

The aim of this stud was to compare the clinical benefits of OCT guided PCI (optical coherence...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures

Millions of people undergo either diagnostic or therapeutic coronary procedures that require sedation. The aim of this...
Dr. Omar Tupayachi -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy